$14.910
+1.806 (+12.11%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 ADARx Pharmaceuticals, Inc. 股票嗎？
ADARx Pharmaceuticals is not a good buy right now due to its significant losses and declining stock performance. The current price is $13.15, which is 43.4% below its 52-week high of $23.21. Additionally, the company reported a net income loss of $25,759,000 in Q2 2026, indicating ongoing financial struggles. The main risk is its high price-to-sales ratio of 240.20, suggesting overvaluation relative to its revenue.
ADRX 股價於 Thursday 收在 $14.91，此前上漲 +12.11%
ADARx Pharmaceuticals, Inc. (ADRX) last closed at $14.9099998, gaining +12.11%. These facts feed the 1-day and 1-week ADRX price prediction above.
預測驅動因素
ADARx Pharmaceuticals, Inc.（ADRX）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
ADRX 季節性分析
相關文章
- International Stocks vs US Stocks in 2026: How the Strong Dollar and Valuations Change the CaseInternational stocks vs US stocks in 2026: how the strong dollar, valuation gaps, Fed hikes and concentration risk shape a smarter global allocation plan now.
- Defensive Stocks in 2026: Is the Rush Into Staples and Healthcare Already Overcrowded?Investors are piling into defensive stocks as tech slides. See why staples and healthcare surged, why valuations look stretched, and how to avoid overpaying.
- Defense Stocks in 2026: How Midterms, the Iran War and a Stalled Budget Shape the OutlookDefense stocks fell after the 2026 midterms. Learn how the Iran war, the $1.5T budget request and the December 11 funding deadline shape the sector outlook.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。